Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Jury finds PeaceHealth, ER doctor not liable for misdiagnosing patient’s stroke
After a three week trial, a jury found that PeaceHealth and Ralph Weiche, MD, acted in accordance with medical protocols in diagnosing Patricia Parker with a psychiatric condition, given her unusual symptoms.
Women less likely to receive DCD heart transplants
Donation after circulatory death heart transplants are gaining popularity in the United States, but men are much more likely to be selected for one.
Mayo Clinic develops AI capable of substantially improving dementia diagnoses
With the software's help, readers are up to three times more accurate and interpretations are nearly twice as fast.
Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving
Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary.

Ultrasound AI could help standardize trauma care

Trauma patients who present with poor blood flow and suspected abdominal hemorrhage are well served by emergency physicians using AI-augmented FAST imaging.

Sam Jones, MD, explains why CMS reduced payments for EP ablation and how it will negatively impact electrophysiology. #HRS #HRS2023 #EPeeps #EPlab #Medicare

Making sense of the huge Medicare reimbursement cuts in electrophysiology

Samuel Jones, MD, examines the large reimbursement reductions in cardiac ablations and what the impact might be on access to care in EP labs.

FDA approves sotagliflozin, the new heart failure drug from Lexicon Pharmaceuticals

The drug, which should be available by the end of June, will be marketed under the name Inpefa.

TAVR among 90-year-old patients: An updated look at mortality, hospital costs and more

In-hospital mortality and other key outcomes have improved in recent years, but treating these older patients is still associated with certain challenges.

artificial intelligence robot evaluates healthcare data

AI organizes heart failure patients into 5 distinct groups, helping cardiologists manage care

Researchers used multiple AI models to evaluate EHR data from more than 322,000 heart failure patients. By identifying these subtypes, the group thinks clinicians could perform better risk assessments and make more informed treatment decisions.

Kenneth Ellenbogen, MD, explains the key EP takeaways from the 2023 Heart Rhythm Society meeting.

Key takeaways from Heart Rhythm 2023

Kenneth Ellenbogen, MD, detailed some of the biggest trends he saw at the three-day event in New Orleans.

artificial intelligence in radiology medical imaging interpretation

Interpretive AI for medical imaging: 5 points of skepticism, idealism

Surveying the landscape of interpretive AI in radiology, two researchers note a yawning gap between great expectations set in the recent past and actual clinical implementations as of spring 2023.

Medtronic acquires insulin patch manufacturer for $738M

The deal represents a significant step forward for Medtronic's diabetes portfolio.

Clinical

Jury finds PeaceHealth, ER doctor not liable for misdiagnosing patient’s stroke

Women less likely to receive DCD heart transplants

Mayo Clinic develops AI capable of substantially improving dementia diagnoses

Private equity firm jumps into vascular health with new investment

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving